i Paul Rosenberg, M.D.
Johns Hopkins Medicine

Alzheimer's Disease Research Center

Paul Rosenberg, M.D.

Associated Investigator
E-mail: prosenb9@jhmi.edu

Publications

  • Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Weintraub D, Newell J, Yesavage J, Lyketsos CG. Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial. Int Psychogeriatr 2015; 27: 2059-2067.
  • Dutcher SK, Rattinger GB, Langenberg P, Chhabra PT, Liu X, Rosenberg PB, Leoutsakos JM, Simoni-Wastila L, Walker LD, Franey CS, Zuckerman IH. Effect of medications on physical function and cognition in nursing home residents with dementia. J Am Geriatr Soc 2014; 62: 1046-1055.
  • Rosenberg PB, Lanctot KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, Mintzer JE. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry.2013; 74: 810-816.
  • Rosenberg P, Mielke M, Appleby B, Oh E, Leotsakos J, Lyketsos C. Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry 2011; 26: 364-372.
  • Rosenberg P, Mielke M, Xue Q, Carlson M. Depressive symptoms predict incident cognitive impairment in cognitive healthy older women. Am J Geriatr Psychiatry 2010; 18: 204-211.